Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK47388 Tablets in Moderate to Severe Active Ulcerative Colitis (Phase II)
CTR20255164Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK47388 in autoimmune colitis, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Feb 2026; status: active.
02
Drugs
HSK47388
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20255164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255164.